Clinical Study of Venetoclax Combined With CACAG Regimen in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia
Clinical trial NCT06084819 · RECRUITING
Trial details
- NCT number
- NCT06084819
- Sponsor
- Chinese PLA General Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-01
- Primary completion
- 2029-01-31
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.